Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study'.

Klopfenstein, Timothée; Gendrin, Vincent; Conrozier, Thierry; Gerazime, Aurélie; Puyraveau, Marc; Zayet, Souheil

Klopfenstein, Timothée; Gendrin, Vincent; Conrozier, Thierry; Gerazime, Aurélie; Puyraveau, Marc; Zayet, Souheil.

Afiliação

Klopfenstein T; Infectious Disease Department, North Franche-Comté Hospital, Montbeliard, France timothee.klopfenstein@hnfc.fr.
Gendrin V; Infectious Disease Department, North Franche-Comté Hospital, Montbeliard, France.
Conrozier T; Rheumatology Department, North Franche-Comté Hospital, Montbeliard, France.
Gerazime A; Methodology unit, Clinical Investigation Center INSERM 1431, CHU Besancon, Besancon, France.
Puyraveau M; Methodology unit, Clinical Investigation Center INSERM 1431, CHU Besancon, Besancon, France.
Zayet S; Infectious Disease Department, North Franche-Comté Hospital, Montbeliard, France.

Ann Rheum Dis ; 82(7): e153, 2023 07.

Article em En | MEDLINE | ID: mdl-34162593

Assuntos

COVID-19; Humanos; Glucocorticoides/uso terapêutico; Síndrome da Liberação de Citocina/tratamento farmacológico; Tratamento Farmacológico da COVID-19

Palavras-chave

COVID-19; anti-inflammatory agents; antirheumatic agents; non-steroidal

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google